VirExit Technologies

VirExit Technologies EBIT per Share

EBIT per Share of VirExit Technologies (VXIT) as of Nov 4, 2026.

EBIT per Share

-0.00USD

YoY

-74.41%

Last updated:

EBIT per Share of VirExit Technologies is 2025 -0.00 USD. EBIT per Share of VirExit Technologies was 2024 -0.00 USD. It decreases by -74.41% higher compared to the previous year.

The VirExit Technologies EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2018
-0.07 USD
Jan 1, 2019
-0.00 USD
Jan 1, 2020
-0.00 USD
Jan 1, 2021
-0.00 USD
Jan 1, 2022
-0.00 USD
Jan 1, 2023
-0.00 USD
Jan 1, 2024
-0.00 USD
Jan 1, 2025
-0.00 USD
The VirExit Technologies EBIT per Share history
YEAREBIT per ShareYoY
-0.00USD-74.41%
-0.00USD+71.82%
-0.00USD-8.83%
-0.00USD-81.86%
-0.00USD+2,399.11%
-0.00USD-97.91%
-0.00USD-96.44%
-0.07USD-58.59%
-0.17USD+53.27%
-0.11USD-63.22%
-0.31USD-69.96%
-1.02USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

VirExit Technologies Stock analysis

What does VirExit Technologies do? VirExit Technologies, Inc. generates revenue through its branded products and services, including disinfectant cleaners, antiviral medications, personal protective equipment (PPE), and sterilization systems under the VirExit(r) and VirExit.com brands. The company targets buyers seeking protective solutions for individual, community, and local economic needs in rural and peri-urban areas globally. Its Lexian product, an Ultraviolet-C-based device, is marketed as a sterilization system for disabling viruses and bacteria through optical diffusion. The firm operates a vertical online marketplace as a primary sales and marketing platform, connecting buyers and sellers of protective products and services. This platform serves as a single source for customers requiring disinfectants, medications, PPE, and sterilization systems. VirExit(r) and VirExit.com are the key brands driving product visibility and sales across its target segments. VirExit Technologies focuses on rural and peri-urban markets worldwide, where it incubates franchise business concepts to support local economies. The company's offerings are designed to address health and safety needs, with Lexian positioned as a specialized sterilization solution. Its business model integrates product sales, franchise incubation, and an online marketplace to serve both individual and community-level demand. VirExit Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about VirExit Technologies stock

On Eulerpool you can find the complete historical development of EBIT per Share VirExit Technologies since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — VirExit Technologies

All Key Metrics — VirExit Technologies